718 related articles for article (PubMed ID: 28278077)
41. Knockdown of ZEB1 suppressed the formation of vasculogenic mimicry and epithelial-mesenchymal transition in the human breast cancer cell line MDA-MB-231.
Liang W; Song S; Xu Y; Li H; Liu H
Mol Med Rep; 2018 May; 17(5):6711-6716. PubMed ID: 29512767
[TBL] [Abstract][Full Text] [Related]
42. 2-Methoxy-5((3,4,5-trimethosyphenyl)seleninyl) phenol (SQ) inhibits cancer cell metastasis behavior of TNBC via suppressing EMT and VEGF.
Zheng D; Wu Z; Han J; Guan Q; Li Z; Zuo D; Zhang W; Wu Y
Chem Biol Interact; 2020 Sep; 329():109202. PubMed ID: 32717189
[TBL] [Abstract][Full Text] [Related]
43. Targeting EGFR of triple-negative breast cancer enhances the therapeutic efficacy of paclitaxel- and cetuximab-conjugated nanodiamond nanocomposite.
Liao WS; Ho Y; Lin YW; Naveen Raj E; Liu KK; Chen C; Zhou XZ; Lu KP; Chao JI
Acta Biomater; 2019 Mar; 86():395-405. PubMed ID: 30660004
[TBL] [Abstract][Full Text] [Related]
44. Triptonide effectively inhibits triple-negative breast cancer metastasis through concurrent degradation of Twist1 and Notch1 oncoproteins.
Zhang M; Meng M; Liu Y; Qi J; Zhao Z; Qiao Y; Hu Y; Lu W; Zhou Z; Xu P; Zhou Q
Breast Cancer Res; 2021 Dec; 23(1):116. PubMed ID: 34922602
[TBL] [Abstract][Full Text] [Related]
45. Antiangiogenic and anti-invasive effects of sunitinib on experimental human glioblastoma.
de Boüard S; Herlin P; Christensen JG; Lemoisson E; Gauduchon P; Raymond E; Guillamo JS
Neuro Oncol; 2007 Oct; 9(4):412-23. PubMed ID: 17622648
[TBL] [Abstract][Full Text] [Related]
46. Chemotherapy enriches for an invasive triple-negative breast tumor cell subpopulation expressing a precursor form of N-cadherin on the cell surface.
Nelson ER; Li S; Kennedy M; Payne S; Kilibarda K; Groth J; Bowie M; Parilla-Castellar E; de Ridder G; Marcom PK; Lyes M; Peterson BL; Cook M; Pizzo SV; McDonnell DP; Bachelder RE
Oncotarget; 2016 Dec; 7(51):84030-84042. PubMed ID: 27768598
[TBL] [Abstract][Full Text] [Related]
47. Evodiamine inhibits vasculogenic mimicry in HCT116 cells by suppressing hypoxia-inducible factor 1-alpha-mediated angiogenesis.
Zeng D; Zhou P; Jiang R; Li XP; Huang SY; Li DY; Li GL; Li LS; Zhao S; Hu L; Ran JH; Chen DL; Wang YP; Li J
Anticancer Drugs; 2021 Mar; 32(3):314-322. PubMed ID: 33394687
[TBL] [Abstract][Full Text] [Related]
48. Hypoxia-induced vasculogenic mimicry formation in human colorectal cancer cells: Involvement of HIF-1a, Claudin-4, and E-cadherin and Vimentin.
Li W; Zong S; Shi Q; Li H; Xu J; Hou F
Sci Rep; 2016 Nov; 6():37534. PubMed ID: 27869227
[TBL] [Abstract][Full Text] [Related]
49. Low Dose of Paclitaxel Combined with XAV939 Attenuates Metastasis, Angiogenesis and Growth in Breast Cancer by Suppressing Wnt Signaling.
Shetti D; Zhang B; Fan C; Mo C; Lee BH; Wei K
Cells; 2019 Aug; 8(8):. PubMed ID: 31416135
[TBL] [Abstract][Full Text] [Related]
50. Tryptophan hydroxylase 1 and 5-HT
Gautam J; Banskota S; Regmi SC; Ahn S; Jeon YH; Jeong H; Kim SJ; Nam TG; Jeong BS; Kim JA
Mol Cancer; 2016 Nov; 15(1):75. PubMed ID: 27871326
[TBL] [Abstract][Full Text] [Related]
51. Hypoxia promotes vasculogenic mimicry formation by the Twist1-Bmi1 connection in hepatocellular carcinoma.
Liu K; Sun B; Zhao X; Wang X; Li Y; Qiu Z; Liu T; Gu Q; Dong X; Zhang Y; Wang Y; Zhao N
Int J Mol Med; 2015 Sep; 36(3):783-91. PubMed ID: 26202447
[TBL] [Abstract][Full Text] [Related]
52. Leptin Promotes Vasculogenic Mimicry in Breast Cancer Cells by Regulating Aquaporin-1.
Han DS; Lee EO
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791252
[TBL] [Abstract][Full Text] [Related]
53. Role of Twist in vasculogenic mimicry formation in hypoxic hepatocellular carcinoma cells in vitro.
Ma JL; Han SX; Zhu Q; Zhao J; Zhang D; Wang L; Lv Y
Biochem Biophys Res Commun; 2011 May; 408(4):686-91. PubMed ID: 21539816
[TBL] [Abstract][Full Text] [Related]
54. Cancer stem-like cells directly participate in vasculogenic mimicry channels in triple-negative breast cancer.
Sun H; Yao N; Cheng S; Li L; Liu S; Yang Z; Shang G; Zhang D; Yao Z
Cancer Biol Med; 2019 May; 16(2):299-311. PubMed ID: 31516750
[TBL] [Abstract][Full Text] [Related]
55. TEM8 marks neovasculogenic tumor-initiating cells in triple-negative breast cancer.
Xu J; Yang X; Deng Q; Yang C; Wang D; Jiang G; Yao X; He X; Ding J; Qiang J; Tu J; Zhang R; Lei QY; Shao ZM; Bian X; Hu R; Zhang L; Liu S
Nat Commun; 2021 Jul; 12(1):4413. PubMed ID: 34285210
[TBL] [Abstract][Full Text] [Related]
56. Serum promotes vasculogenic mimicry through the EphA2/VE-cadherin/AKT pathway in PC-3 human prostate cancer cells.
Yeo C; Lee HJ; Lee EO
Life Sci; 2019 Mar; 221():267-273. PubMed ID: 30797819
[TBL] [Abstract][Full Text] [Related]
57. Targeting Syndecan-1, a molecule implicated in the process of vasculogenic mimicry, enhances the therapeutic efficacy of the L19-IL2 immunocytokine in human melanoma xenografts.
Orecchia P; Conte R; Balza E; Pietra G; Mingari MC; Carnemolla B
Oncotarget; 2015 Nov; 6(35):37426-42. PubMed ID: 26460958
[TBL] [Abstract][Full Text] [Related]
58. SANT, a novel Chinese herbal monomer combination, decreasing tumor growth and angiogenesis via modulating autophagy in heparanase overexpressed triple-negative breast cancer.
Li QW; Zhang GL; Hao CX; Ma YF; Sun X; Zhang Y; Cao KX; Li BX; Yang GW; Wang XM
J Ethnopharmacol; 2021 Feb; 266():113430. PubMed ID: 33011366
[TBL] [Abstract][Full Text] [Related]
59. Design, synthesis, and validation of novel nitrogen-based chalcone analogs against triple negative breast cancer.
Elkhalifa D; Siddique AB; Qusa M; Cyprian FS; El Sayed K; Alali F; Al Moustafa AE; Khalil A
Eur J Med Chem; 2020 Feb; 187():111954. PubMed ID: 31838326
[TBL] [Abstract][Full Text] [Related]
60. TRPS1 knockdown inhibits angiogenic vascular mimicry in human triple negative breast cancer cells.
Wu M; Sun X; Wang T; Zhang M; Li P
Clin Transl Oncol; 2022 Jan; 24(1):145-153. PubMed ID: 34216368
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]